AS9120B, ISO 9001:2015, and FAA AC 0056B Accredited
| Alternative NSN: 6505-01-656-4667 |
| Item Name:Fentanyl Transdermal System |
| NIIN: 016564667 |
| NCB Code: USA (01) |
| Manufacturers: Actavis Pharma Inc , Janssen Pharmaceuticals Inc , Mallinckrodt Inc , Mylan Pharmaceuticals Inc , Par Pharmaceutical Inc , Sandoz Inc |
ASAP Aerospace, owned and operated by ASAP Semiconductor, is the latest parts procurement platform for the aerospace and aviation industry. Customers can easily search our database to find NSN parts like Fentanyl Transdermal System NDC00378-9123-98, NDC00406-9075-76, NDC00591-3213-72, NDC00781-7243-55, NDC49884-0763-78 of Mylan Pharmaceuticals Inc, Mallinckrodt Inc, Actavis Pharma Inc, Sandoz Inc, Par Pharmaceutical Inc with NSN 6505-01-656-4667.
NSN 6505-01-656-4667, National Stock Number, is a 13-digit serial number assigned by the US DLA to an item that is bought, stored, and sold via the federal supply chain. Unlike part numbers, NSNs are not arbitrary and follow a specific classification system.
| Part No | Item Name | Manufacturer | QTY | RFQ |
|---|---|---|---|---|
| NDC00378-9123-98 | Fentanyl Transdermal System | Mylan Pharmaceuticals Inc | Avl | RFQ |
| NDC00406-9075-76 | Fentanyl Transdermal System | Mallinckrodt Inc | Avl | RFQ |
| NDC00591-3213-72 | Fentanyl Transdermal System | Actavis Pharma Inc | Avl | RFQ |
| NDC00781-7243-55 | Fentanyl Transdermal System | Sandoz Inc | Avl | RFQ |
| NDC49884-0763-78 | Fentanyl Transdermal System | Par Pharmaceutical Inc | Avl | RFQ |
| NDC50458-0093-05 | Fentanyl Transdermal System | Janssen Pharmaceuticals Inc | Avl | RFQ |
| MRC | Criteria | Characteristic |
|---|---|---|
| FEAT | Special Features | ROUTE: TRANSDERMAL; DOSE FORM: PATCH, TRANSDERMAL 72 HOURS; STRENGTH: 75 MCG/HOUR; DEA CONTROLLED II SUBSTANCE; INDIVIDUALLY SEALED; CONTAINS FIVE (75 MCG/HR) TRANSDERMAL SYSTEMS; STORE IN ORIGINAL UNOPENED POUCH. STORE UP TO 20 C TO 25 C (68 F TO 77 F; STRICT ADHERENCE TO THE RECOMMENDED HANDLING AND DISPOSAL INSTRUCTIONS ON PRODUCT INSERT IS OF THE UTMOST IMPORTANCE TO PREVENT ACCIDENTAL EXPOSURE; EXPOSURE OF FENTANYL TRANSDERMAL SYSTEM APPLICATION SITE AND SURROUNDING AREA TO DIRECT EXTERNAL HEAT SOURCES, SUCH AS HEATING PADS, SAUNAS, HOT TUBS AND HEATED WATER BEDS MAY INCREASE FENTANYL ABSORPTION AND RESULT IN FATAL OVERDOSE OF FENTANYL AND DEATH; PATIENTS WHO DEVELOP FEVER OR INCREASED CORE BODY TEMPERATURE DUE TO STRENOUS EXERTION ARE ALSO AT RISK FOR INCREASED FENTANYL EXPOSURE AND MAY REQUIRE AN ADJUSTMENT IN THE DOSE OF FENTANYL TRANSDERMAL SYSTEM TO AVOID OVERDOSE |
| CSLZ | Usual Dose | 75 MCG/HR |
| CBBL | Features Provided | INDIVIDUALLY SEALED |
| CRYC | Controlled Substance Classification | SCHEDULE II |
| CXCY | Part Name Assigned By Controlling Agency | DURAGESIC-75 (FENTANYL TRANSDERMAL SYSTEM) 75MCG/HR, 5S |
| MRC | Decoded Requirement | Clear Text Reply |
| 6505-00-001-3345 | 6505-00-001-7673 | 6505-00-001-7674 | 6505-00-001-9186 | 6505-00-003-3022 | 6505-00-003-3026 | 6505-00-003-5112 | 6505-00-003-5116 | 6505-00-004-6652 |
Before You Go, You Should Check Out Our NSN Parts Catalog! You Can Get A Competitive Quote Within Just 15 Minutes of Submitting Your RFQ.
Request for Quote